ProPhase Labs, Inc.
PRPH
Rank in Stocks
#33986
ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously... ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously known as The Quigley Corporation), operates as a diversified company with two main areas of focus: Consumer Products and Diagnostic Services. Through its Consumer Products division, ProPhase Labs is actively involved in the entire process—from researching and developing to manufacturing, distributing, marketing, and selling—a range of over-the-counter (OTC) healthcare items and nutritional supplements within the United States. Notable offerings include dietary supplements like Legendz XL, which supports male sexual health, and Triple Edge XL, formulated to enhance energy and stamina. The Diagnostic Services segment provides crucial testing solutions, including PCR tests for SARS-CoV-2 (COVID-19) and its variant mutations, using both saliva and nasal swab collection methods. This segment also offers molecular testing for other respiratory pathogens and supplies personal genomics products and services. Additionally, ProPhase Labs extends its capabilities by providing comprehensive contract manufacturing services, covering product development, pre-commercialization activities, production, warehousing, and distribution. The company's diverse products and services reach consumers through a broad network of national chain drug stores, various regional retailers, and online platforms.
Share Price
$0.00487
Last synced: 2026-11-13
Market Cap
$68.26K
Change (1 day)
5.87%
Change (1 year)
-99.82%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade ProPhase Labs, Inc. (PRPH)
Category
Healthcare
Dividend yield history for ProPhase Labs, Inc. (PRPH)
ProPhase Labs, Inc. (stock symbol: PRPH) dividend yield (TTM) as of 2025: 0.00%
Average dividend yield, last 5 years : 4.12%
Average dividend yield, last 5 years : 4.12%
Dividend yield history for ProPhase Labs, Inc. (PRPH) from 2000 to 2026
Dividend Yield at the end of each year (TTM)
| Year | Dividend Yield | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | -100.00% |
| 2022 | 12.25% | 46.71% |
| 2021 | 8.35% | 0.00% |
| 2020 | 0.00% | -100.00% |
| 2019 | 12.78% | -21.60% |
| 2018 | 16.30% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | 0.00% |
| 2005 | 0.00% | 0.00% |
| 2004 | 0.00% | 0.00% |
| 2003 | 0.00% | 0.00% |
| 2002 | 0.00% | 0.00% |
| 2001 | 0.00% | 0.00% |
| 2000 | 0.00% | 0.00% |
Dividend yields (TTM) for similar companies or competitors
| Company | Dividend Yield | Country |
|---|---|---|
| 1.63% |
DE
|
|
| 1.47% |
DE
|
|
| 2.92% |
JP
|
|
| 0.18% |
CH
|
|
| 0.00% |
IL
|
Questions about ProPhase Labs, Inc.'s dividend yield
What was ProPhase Labs, Inc.'s dividend yield in 2025?
In 2025, ProPhase Labs, Inc.'s dividend yield was 0.00%, compared with 0.00% in 2024.
How has ProPhase Labs, Inc.'s dividend yield changed since 2020?
From 2020 to 2025, ProPhase Labs, Inc.'s dividend yield was highest in 2022 (12.25%) and lowest in 2025 (0.00%).
How does ProPhase Labs, Inc.'s dividend yield compare with similar companies?
ProPhase Labs, Inc.'s dividend yield (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is Takeda Pharmaceutical Company Limited, with 2.92%.